Potentielle Anwendungsgebiete Ebenfalls zeigen GLP-1-Agonisten stellenweise antidepressive und neuroprotektive Eigenschaften in der Anwendung bei Diabetikern
Each new study adds to the picture that injectable GLP-1 receptor agonists do not transfer into breast milk in meaningful amounts
Molecular Characteristics Molecular Type: Synthetic pentadecapeptide research compound Structure: Linear peptide chain (15 amino acids) Stability: High when stored under recommended laboratory conditions Molecular Weight: Sequence-dependent Molecular Stability and Storage Profile Supplied as a lyophilized powder for enhanced long-term stability Long-term storage: Store at 20C to preserve molecular integrity Sensitive to moisture and prolonged light exposure Predictable degradation above room temperature Reconstituted solutions remain stable for approximately 2448 hours under refrigeration Solubility and Reconstitution Characteristics Bacteriostatic water Sterile saline Acidic buffers Compatible analytical-grade organic solvents Technical Specifications product Name BPC-157 10mg cas 137525-51-0 purity 99% (HPLC verified) unit Size 10 mg vial form Lyophilized powder synthesis Solid-Phase Peptide Synthesis (SPPS) analytical HPLC, Mass Spectrometry, UV Spectrophotometry molecular Structure Linear peptide chain stability High when stored under recommended conditions Analytical Validation and Quality Assurance High-Performance Liquid Chromatography (HPLC) purity confirmation Mass Spectrometry (MS) molecular identity and sequence verification UV spectrophotometric concentration analysis Batch identity and consistency verification Endotoxin and microbial contamination screening Regulatory and Compliance Statement BPC-157 10mg is supplied strictly for laboratory research and scientific investigation
Study selection was guided by the following PICO-derived questions In individuals with fibromyalgia, does increased oxidative stress or mitochondrial dysfunction (compared to healthy controls) correlate with greater symptom severity and inflammatory biomarkers
When to reassess If GI symptoms worsen instead of improving over the first 2-3 weeks of a step, if you cannot keep food down, or if you have severe persistent abdominal pain (especially with back radiation), pause and consult a qualified clinician
